Caidya, a leading global provider of clinical trial solutions, is pleased to announce a transition in its executive leadership. Barbara Lopez Kunz, a distinguished member...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Neurocrine Biosciences, Inc announced the launch of a new sprinkle formulation of INGREZZA capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the...
Exscientia plc announced that it has entered into an agreement to acquire GT Apeiron's interest in its oral CDK7 inhibitor program, thereby gaining full...
NMDP BioTherapies, a leader in cell and gene therapy development support, and the NMDP BioTherapies Cord Blood Bank Alliance (CBBA), a partnership between NMDP...
